A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

drug protocol number
MOR-005
drug sponsor
BioMarin Pharmaceutical Inc.
drug study
BMN 110
drug trial site
KFSH & RC-R
drug status
Completed
drug phase